Articles Tagged with “Avandia FDA Glaxo Smith Klein personal injury Risoglitazone”

The officials voting today were presented with multiple choice questions. Question three had a choice of

A. The data provides sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Rosiglitazone (Avandia).

B. The data does not provide sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Avandia.

Badges
Contact Information